Active Ingredient: ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
Proprietary Name: VASOCON-A
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 0.5%;0.05%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018746
Product Number: 002
Approval Date: Jul 11, 1994
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information
